FPAS
TXG icon

Focus Partners Advisor Solutions’s 10x Genomics TXG Stock Holding History

Focus Partners Advisor Solutions’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Sell
14,787
-4,131
-22% -$108K ﹤0.01% 758
2026
Q1 		$401K Sell
18,918
-964
-5% -$19.3K ﹤0.01% 870
2025
Q4 		$324K Sell
19,882
-2,097
-10% -$31.7K ﹤0.01% 864
2025
Q3 		$329K Sell
21,979
-3,124
-12% -$40.7K ﹤0.01% 871
2025
Q2 		$291K Buy
+25,103
New +$229K ﹤0.01% 877

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focus Partners Advisor Solutions's TXG Position: Q2 2026 in Review

Focus Partners Advisor Solutions reduced its 10x Genomics (TXG) stake by 22% in Q2 2026, selling an estimated $108K and leaving 14,787 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #758.

Focus Partners Advisor Solutions first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Focus Partners Advisor Solutions held 14,787 shares of 10x Genomics worth $567K as of Q2 2026.
  • Focus Partners Advisor Solutions sold 4,131 10x Genomics shares in Q2 2026, an estimated $108K.
  • 10x Genomics made up ﹤0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #758 holding.
  • Focus Partners Advisor Solutions first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.